Roche says EU agency recommends Avastin for cervical cancer

Reuters

ZURICH (Reuters) - Roche said on Friday that European regulators had recommended approval of its drug Avastin in combination with chemotherapy as a treatment for women with an advanced form of cancer of the cervix. Avastin, which is already approved in Europe to treat advanced stages of breast cancer, colorectal cancer, non-small cell lung cancer, kidney cancer and ovarian cancer, was the Basel-based drugmaker's biggest seller last year with sales of 6.42 billion Swiss francs ($6.76 billion). (Reporting By Zurich Slot; Editing by David Goodman)